Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control
Patients with urothelial carcinoma demonstrated improved overall survival as well. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Beta Blockers May Avert Cancer-Drug Cardiotoxicity Beta Blockers May Avert Cancer-Drug Cardiotoxicity
Treatment with some beta blockers may protect cardiac contractile function during anthracycline or trastuzumab therapy, suggests a meta-analysis that also confirmed such protection by dexrazoxane.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 14, 2022 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Cardiotoxic medication poisoning - Cole JB, Arens AM.
Beta-blockers and calcium channel blockers result in a disproportionate number of fatalities from cardiac medication overdoses, and share similar characteristics. High-dose insulin is a superior therapy for both overdoses, but is likely synergistic with va... (Source: SafetyLit)
Source: SafetyLit - April 26, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Discharge Beta Blockers, RASi Cut Late Risk in MI, Mid-Range EF Discharge Beta Blockers, RASi Cut Late Risk in MI, Mid-Range EF
There were fewer cardiac events at 2 years for MI patients with LVEF 40% to 49% discharged on beta blockers and, separately, renin-angiotensin-system inhibitors in a propensity-matched cohort study.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 16, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Can You Drink Coffee While Taking Beta-Blockers?
Title: Can You Drink Coffee While Taking Beta-Blockers?Category: Diseases and ConditionsCreated: 2/9/2022 12:00:00 AMLast Editorial Review: 2/9/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 9, 2022 Category: Cardiology Source Type: news

A Look at Long-Term Beta Blockers After MI in the PCI Era A Look at Long-Term Beta Blockers After MI in the PCI Era
Reassessing beta-blocker therapy in patients after the initial myocardial infarction treatment phase.ACC.org (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 8, 2021 Category: Cardiology Tags: Cardiology Article Source Type: news

Are Long-Term Beta Blockers Following MI in the PCI Era? Are Long-Term Beta Blockers Following MI in the PCI Era?
Reassessing beta-blocker therapy in patients after the initial myocardial infarction treatment phase.ACC.org (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 8, 2021 Category: Cardiology Tags: Cardiology Article Source Type: news

ACE Inhibitors vs. Beta Blockers
Title: ACE Inhibitors vs. Beta BlockersCategory: MedicationsCreated: 10/5/2017 12:00:00 AMLast Editorial Review: 12/6/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - December 6, 2021 Category: Cardiology Source Type: news

What Are the LongTerm Side Effects of BetaBlockers
What Are the Long-Term Side Effects of Beta-Blockers? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 30, 2021 Category: General Medicine Source Type: news

Beta-Blocker Therapy and Survival After Hip Fracture Surgery Beta-Blocker Therapy and Survival After Hip Fracture Surgery
This study found that ongoing beta-blocker therapy was associated with a significant reduction in the risk of mortality within the first year after hip fracture surgery.Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2021 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Beta-Blockers May Reduce Mortality After Hip Fracture Surgery Beta-Blockers May Reduce Mortality After Hip Fracture Surgery
Data from a large Swedish Registry suggest that use of beta-blockers before and after surgery was associated with a 42% reduction of risk in the first postoperative year.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 4, 2021 Category: Consumer Health News Tags: Orthopaedics News Source Type: news

Association Between Premorbid Beta-Blocker Exposure and Sepsis Outcomes-The Beta-Blockers in European and Australian/American Septic Patients (BEAST) Study
Conclusions: This study suggests that β-blocker exposure pr ior to sepsis, especially to noncardioselective β blockers, may be associated with better outcome. The findings suggest prospective evaluation of β-blocker use in the management of sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 8, 2021 Category: Consumer Health News Source Type: news

Common blood pressure pills taken by millions of Brits may raise the risk of psoriasis, study warns
A review of 21 studies by Korean researchers found common drugs ACE inhibitors, beta blockers, calcium channel blockers (CCBs) and thiazide diuretics, increased the risk of psoriasis. (Source: the Mail online | Health)
Source: the Mail online | Health - October 6, 2021 Category: Consumer Health News Source Type: news

Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients
Might nonselective beta-blockers such as carvedilol, nadolol, and propranolol decrease the risk of hepatocellular carcinoma among patients with cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Beta-Blocker Reduces Lung Inflammation in Critical COVID-19 Beta-Blocker Reduces Lung Inflammation in Critical COVID-19
In a pilot trial, intravenous metoprolol given to patients with acute respiratory distress syndrome brought on by COVID-19 was safe, reduced lung inflammation, and improved oxygenation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 2, 2021 Category: Cardiology Tags: Cardiology News Source Type: news